Concepedia

Karen E. DeBell

KE

Statistics

Publications

19

Citations

815

H-Index

16

Active since

1984

Affiliations

Center for Biologics Evaluation and Research(Current)

Center for Drug Evaluation and Research

National Institutes of Health

United States Food and Drug Administration

University of Chieti-Pescara

Karen E. DeBell is an author at Center for Biologics Evaluation and Research specializing in life sciences, signal transduction, and cell signaling.

Publications per year

1984–2012

19

Publications

19

Phospholipase C–mediated hydrolysis of PIP2 releases ERM proteins from lymphocyte membrane

Jian-Jiang Hao, Yin Liu, Michael J. Kruhlak et al. · The Journal of Cell Biology · 2009 · 141 citations · Full text

, , +15

Membrane Raft-Dependent Regulation of Phospholipase Cγ-1 Activation in T Lymphocytes

Maria-Concetta Verı́, Karen E. DeBell, Maria‐Cristina Seminario et al. · Molecular and Cellular Biology · 2001 · 63 citations · Full text

, , +17

The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.

Bogdan A. Stoica, Karen E. DeBell, Larry J Graham et al. · PubMed · 1998 · 59 citations

, , +17

Cbl-mediated Regulation of T Cell Receptor-induced AP1 Activation

Barbara L. Rellahan, Laurie Graham, Bogdan A. Stoica et al. · Journal of Biological Chemistry · 1997 · 59 citations · Full text

, , +17

CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection

Rodolfo Silva, Susan Moir, Lela Kardava et al. · Blood · 2011 · 57 citations · Full text

, , +9

1–5 of 19